Search results
OC researchers testing vision-loss treatments by sending mice to space
KABC 7 Los Angeles· 6 days agoAs we get older, we all face the risk of age-related macular degeneration. Researchers tell us how...
Melatonin Shows Promise in Reducing Macular Degeneration Risk
WebMD· 5 days agoBeyond their reputation as sleep aids, melatonin supplements might harbor a surprising potential: as a remedy for vision damage. In a study of more than 120,000 people ages 50 or older with ...
EyeDefense Vitamins Introduces MacularControl Essential, A Doctor-Formulated Eye Health Product
Digital Journal· 2 days agoThis press release is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please check with your doctor. The news site hosting this press ...
RevOpsis and Kemwell partner to boost biologic development
Pharmaceutical Technology via Yahoo Finance· 6 days agoThis collaboration aligns with our mission to develop groundbreaking treatments expeditiously, and...
RevOpsis and Kemwell Biopharma Enter into Strategic Manufacturing Partnership to Expedite...
Lodi News-Sentinel· 7 days agoThis collaboration aims to accelerate the development of RevOpsis' lead candidate, RO-104, a first-in-class tri-specific biologic for the treatment of neovascular
Tackling blindness with focus on vision
China Daily· 7 days ago"I never expected to not only have my eyes saved, but also continue to save lives in the operating room," said an anesthesiologist surnamed Cheng in Chongqing municipality. After being diagnosed ...
Akari Therapeutics (NASDAQ:AKTX) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 4 days agoStockNews.com initiated coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Free Report) in a report released on Wednesday morning. The firm issued a sell rating on the biopharmaceutical ...
5 Reasons Vision Technology Companies Are Building Brands In 2024
Forbes· 6 days agoThe eyes are a window into full-body health and new technology-driven shifts further underscore the...
REGENXBIO Inc. (NASDAQ:RGNX) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 4 days agoShares of REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the thirteen analysts that are covering the stock, Marketbeat.com reports ...
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Short Interest Update
ETF DAILY NEWS· 7 days agoOutlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 1,660,000 ...